There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

The CDC recommends getting an updated 2024-2025 COVID-19 vaccine to protect against potentially serious illness associated with the latest variants of the virus, noting that protection from vaccines ...

RSV vaccines have reportedly fallen since U.S. regulators narrowed the recommended age range and frequency for the shots.

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

More than 13,500 people contracted COVID-19 in Connecticut between Aug. 1 and Oct. 5, according to the most recent state data ...

JMP Securities analyst Roy Buchanan reiterated a Buy rating on Enanta Pharmaceuticals (ENTA – Research Report) today and set a price ...

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...